Amgen

Can Amgen's new-and-improved Kyprolis kick-start myeloma sales?
Fierce Pharma
Fri, 08/31/18 - 11:53 pm
Amgen
Kyprolis
Multiple Myeloma
Gilead steals new commercial chief from Amgen to tackle big sales challenges
Fierce Pharma
Wed, 08/29/18 - 11:59 am
Gilead Sciences
Amgen
Laura Hamill
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
RAPS.org
Tue, 08/28/18 - 08:00 pm
Pfizer
FDA
biosimilars
Amgen
Genentech
drug ads
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Tue, 08/21/18 - 10:06 am
Aimovig
Amgen
Novartis
migraines
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Thu, 08/9/18 - 03:57 pm
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Two Pharma Giants Successfully Navigate a Challenging Climate
Yahoo/Zacks.com
Sat, 08/4/18 - 11:57 am
Donald Trump
drug pricing
Merck
Amgen
Clover Initiates Ph I Study of Enbrel Biosimilar in China
CP Wire
Wed, 08/1/18 - 10:35 am
Clover BioPharmaceuticals
Enbrel
Amgen
biosimilars
SCB-808
China
Amgen's new migraine drug hits insurance hurdles
Reuters
Thu, 07/26/18 - 07:41 pm
Amgen
migraines
Aimovig
insurers
New drug sales power Amgen’s Q2 results
Alphastreet
Thu, 07/26/18 - 07:15 pm
Amgen
earnings
Amgen R&D chief Sean Harper hits the exits with a one-way ticket to early-stage biotech
Endpoints
Thu, 07/26/18 - 07:06 pm
Amgen
R&D
Sean Harper
biotech
7 companies to watch during Q2 earnings
Biopharma Dive
Sun, 07/22/18 - 12:41 pm
earnings
Biogen
Gilead Sciences
Amgen
Celgene
AbbVie
Pfizer
Spark Therapeutics
Pfizer gets FDA approval for drug similar to Amgen's Neupogen
Marketwatch
Sat, 07/21/18 - 01:22 pm
Pfizer
FDA
biosimilars
Amgen
Neupogen
Nivestym
Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Fierce Pharma
Mon, 07/16/18 - 10:34 pm
Amgen
biosimilars
Neulasta
Alexion
M&A
Amgen, UCB are back pitching once-rejected osteoporosis drug romo to the FDA — but big hurdles lie ahead
Endpoints
Fri, 07/13/18 - 11:57 am
Amgen
UCB Pharma
osteoporosis
romosozumab
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
migraines
Amgen
Novartis
Aimovig
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Amgen
ABP 710
JNJ
Merck
Remicade
biosimilars
rheumatoid arthritis
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Tue, 06/26/18 - 09:47 am
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
Akero picks up $65M to advance Amgen-licensed NASH drug
Fierce Biotech
Mon, 06/25/18 - 09:28 am
Akeron Therapeutics
NASH
Amgen
AKR-001
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease
Could an old Amgen-developed RA drug make CAR-T treatments safer?
Fierce Biotech
Thu, 06/7/18 - 10:08 am
CAR-T
cytokine release syndrome
Kymriah
Yescarta
Amgen
Kineret

Pages